Exercise Hemodynamics and Mitochondrial Oxidative Capacity in Disease Stages of Wild-Type Transthyretin Amyloid Cardiomyopathy

被引:0
|
作者
Ladefoged, Bertil [1 ]
Pedersen, Anders Dahl [1 ]
Seefeldt, Jacob [1 ]
Nielsen, Bent Roni Ranghoj [1 ]
Eiskjaer, Hans [1 ]
Lichscheidt, Emil [1 ]
Clemmensen, Tor [1 ]
Gillmore, Julian David [2 ]
Poulsen, Steen Hvitfeldt [1 ]
机构
[1] Aarhus Univ Hosp, Dept Cardiol, Palle Juul Jensens Blvd 99, DK-8200 Aarhus, Denmark
[2] Royal Free Hosp, Natl Amyloidosis Ctr, London, England
来源
关键词
cardiac amyloidosis; invasive hemodynamics; mitochondrial oxidative phosphorylation; transthyretin amyloid cardiomyopathy; HEART-FAILURE; EJECTION FRACTION; PARAMETERS; RESERVE; FLOW;
D O I
10.1161/JAHA.124.034213
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Wild-type transthyretin amyloid (ATTRwt) cardiomyopathy is increasingly recognized in the development of heart failure. The link between cardiac performance, hemodynamics, and mitochondrial function in disease stages of ATTRwt has not previously been studied but may provide new insights into the pathophysiology and clinical performance of the patients.Methods and Results The study investigated 47 patients diagnosed with ATTRwt at Aarhus University Hospital, Denmark. Patients were stratified according to the disease stages of the National Amyloidosis Centre (NAC) as NAC I with low levels of NT-proBNP (N-terminal pro-B-type natriuretic peptide) (NAC I-L, n=14), NAC I with high levels NT-proBNP (NAC I-H, n=20), and NAC II-III (n=13). Exercise testing with simultaneous right heart catheterization was performed in all patients. Endomyocardial biopsies were collected from the patients and the mitochondrial oxidative phosphorylation capacity was assessed. All NAC disease groups, even in the NAC I-L group, a significant abnormal increase in biventricular filling pressures were noted during exercise while the filling pressures was normal or near normal at rest. The inotropic response to exercise was reduced with diminished increase in cardiac output which was significantly more pronounced in the NAC I-H (Diff. -2.4, 95% CI (-4.2: -0.7), P=0.00) and the NAC II-III group (Diff: -3.1 L/min, 95% CI (-5.2: -1.1), P=0.00) compared with the NAC I-L group. The pulmonary artery wedge pressure to cardiac output ratio at peak exercise was significantly different between NAC I-L and NAC II-III (Diff: 1.6 mm Hg*min/L, 95% CI (0.01:3.3, P=0.04)). Patients with ATTRwt had a reduced oxidative phosphorylation capacity which correlated to left ventricular mass but not to cardiac output capacity.Conclusions An abnormal restrictive left ventricle and right ventricle response to exercise was demonstrated, even present in patients with early-stage ATTRwt. In more advanced disease stages a progressive impairment of the pressure-flow relationship was noted. The myocyte energetics is deranged but not associated to the contractile reserve or restrictive filling characteristics in ATTRwt.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] THE EFFECT OF TRIMETAZIDINE ON INVASIVE HEMODYNAMICS AND MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION CAPACITY IN WILD-TYPE TRANSTHYRETIN CARDIOMYOPATHY
    Ladefoged, Bertil
    Pedersen, Anders Lehmann Dahl
    Dybro, Anne
    Gillmore, Julian David
    Poulsen, Steen Hvitfeldt
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 350 - 350
  • [2] Assessment of transthyretin instability in patients with wild-type transthyretin amyloid cardiomyopathy
    Iino, Takuya
    Nagao, Manabu
    Tanaka, Hidekazu
    Yoshikawa, Sachiko
    Asakura, Junko
    Nishimori, Makoto
    Shinohara, Masakazu
    Harada, Amane
    Watanabe, Shunsuke
    Ishida, Tatsuro
    Hirata, Ken-ichi
    Toh, Ryuji
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [3] Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey
    Nativi-Nicolau, Jose
    Siu, Alfonso
    Dispenzieri, Angela
    Maurer, Mathew S.
    Rapezzi, Claudio
    Kristen, Arnt, V
    Garcia-Pavia, Pablo
    LoRusso, Samantha
    Waddington-Cruz, Marcia
    Lairez, Olivier
    Witteles, Ronald
    Chapman, Doug
    Amass, Leslie
    Grogan, Martha
    [J]. JACC: CARDIOONCOLOGY, 2021, 3 (04): : 537 - 546
  • [4] Molecular mechanisms and emerging therapies in wild-type transthyretin amyloid cardiomyopathy
    Wu, Danni
    Chen, Wei
    [J]. HEART FAILURE REVIEWS, 2024, 29 (02) : 511 - 521
  • [5] Molecular mechanisms and emerging therapies in wild-type transthyretin amyloid cardiomyopathy
    Danni Wu
    Wei Chen
    [J]. Heart Failure Reviews, 2024, 29 : 511 - 521
  • [6] Endothelial Function Is Preserved in Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy
    Hashimoto, Yu
    Yamaji, Takayuki
    Kitagawa, Toshiro
    Nakano, Yukiko
    Kajikawa, Masato
    Yoshimura, Kenichi
    Chayama, Kazuaki
    Goto, Chikara
    Tanigawa, Syunsuke
    Mizobuchi, Aya
    Harada, Takahiro
    Yusoff, Farina Mohamad
    Kishimoto, Shinji
    Maruhashi, Tatsuya
    Fujita, Asuka
    Uchiki, Toshio
    Nakashima, Ayumu
    Higashi, Yukihito
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (07)
  • [7] Familial wild-type transthyretin cardiomyopathy
    Benson, Merrill D.
    Berk, John L.
    Connors, Lawreen H.
    Dasgupta, Noel R.
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2017, 24 : 91 - 92
  • [8] Prognostic Role of Cardiopulmonary Exercise Testing in Wild-Type Transthyretin Amyloid Cardiomyopathy Patients Treated With Tafamidis
    Dalia, Tarun
    Acharya, Prakash
    Chan, Wan-chi
    Sauer, Andrew J.
    Weidling, Robert
    Fritzlen, John
    Goyal, Amandeep
    Miller, Dana
    Knipper, Elaine
    Porter, Charles B.
    Shah, Zubair
    [J]. JOURNAL OF CARDIAC FAILURE, 2021, 27 (11) : 1285 - 1289
  • [9] Assessment of Physical Performance in Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy Evaluated by Cardiopulmonary Exercise Testing
    Willixhofer, R.
    Rettl, R.
    Kronberger, C.
    Duca, F.
    Binder, C.
    Kammerlander, A.
    Kastner, J.
    Bergler-Klein, J.
    Badr-Eslam, R.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 : S479 - S479
  • [10] Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study
    Tini, Giacomo
    Musumeci, Beatrice
    Milani, Paolo
    Zampieri, Mattia
    Caponetti, Angelo Giuseppe
    Fabris, Francesca
    Foli, Andrea
    Argiro, Alessia
    Mazzoni, Carlotta
    Gagliardi, Christian
    Longhi, Simone
    Saturi, Giulia
    Vergaro, Giuseppe
    Aimo, Alberto
    De Fazio, Ludovica
    Varra, Guerino Giuseppe
    Serenelli, Matteo
    Fabbri, Gioele
    De Michieli, Laura
    Palmiero, Giuseppe
    Ciliberti, Giuseppe
    Carigi, Samuela
    Zanoletti, Margherita
    Mandoli, Giulia Elena
    Lucchi, Giulia Ricci
    Rella, Valeria
    Monti, Enrico
    Gardini, Elisa
    Bartolotti, Michela
    Crotti, Lia
    Merli, Elisa
    Mussinelli, Roberta
    Vianello, Pier Filippo
    Cameli, Matteo
    Marzo, Francesca
    Guerra, Federico
    Limongelli, Giuseppe
    Cipriani, Alberto
    Perlini, Stefano
    Obici, Laura
    Perfetto, Federico
    Barbato, Emanuele
    Porto, Italo
    Sinagra, Gianfranco
    Merlo, Marco
    Emdin, Michele
    Biagini, Elena
    Cappelli, Francesco
    Palladini, Giovanni
    Canepa, Marco
    [J]. ESC HEART FAILURE, 2024,